Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan I Luengo

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Future Medicinal Chemistry|April 30, 2011
Yin and Yang in medicinal chemistry: what does drug-likeness mean?Ricardo Macarrón, Juan I Luengo
Bioorganic & Medicinal Chemistry Letters|July 31, 2020
Exploiting binding-site arginines in drug design: Recent examplesHong Lin, Juan I Luengo
Bioorganic & Medicinal Chemistry Letters|April 9, 2019
Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitorsHong Lin, Juan I Luengo
Organic Letters|March 12, 2004
An efficient synthesis of 3-substituted 3H-pyrimidin-4-onesJae Uk Jeong, Xiaohong Chen, Attiq Rahman, et al.
ACS Medicinal Chemistry Letters|July 18, 2019
Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) InhibitorsHong Lin, Min Wang, Yang W Zhang, et al.
Drug Discovery Today|May 24, 2011
Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experienceDana E Vanderwall, Nancy Yuen, Mohammad Al-Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2009
Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitorsMark A Seefeld, Meagan B Rouse, Kenneth C McNulty, et al.
SLAS Discovery : Advancing Life Sciences R & D|April 28, 2018
Nuisance Compounds, PAINS Filters, and Dark Chemical Matter in the GSK HTS CollectionSubhas J Chakravorty, James Chan, Marie Nicole Greenwood, et al.
Stem Cells (Dayton, Ohio)|November 29, 2008
Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonistConnie L Erickson-Miller, Evelyne Delorme, Shin-Shay Tian, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
[3a,4]-Dihydropyrazolo[1,5a]pyrimidines: Novel, Potent, and Selective Phosphatidylinositol-3-kinase β InhibitorsHongyi Yu, Michael L Moore, Karl Erhard, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Future Medicinal Chemistry|April 30, 2011
Yin and Yang in medicinal chemistry: what does drug-likeness mean?Ricardo Macarrón, Juan I Luengo
Bioorganic & Medicinal Chemistry Letters|July 31, 2020
Exploiting binding-site arginines in drug design: Recent examplesHong Lin, Juan I Luengo
Bioorganic & Medicinal Chemistry Letters|April 9, 2019
Nucleoside protein arginine methyltransferase 5 (PRMT5) inhibitorsHong Lin, Juan I Luengo
Organic Letters|March 12, 2004
An efficient synthesis of 3-substituted 3H-pyrimidin-4-onesJae Uk Jeong, Xiaohong Chen, Attiq Rahman, et al.
ACS Medicinal Chemistry Letters|July 18, 2019
Discovery of Potent and Selective Covalent Protein Arginine Methyltransferase 5 (PRMT5) InhibitorsHong Lin, Min Wang, Yang W Zhang, et al.
Drug Discovery Today|May 24, 2011
Molecular clinical safety intelligence: a system for bridging clinically focused safety knowledge to early-stage drug discovery - the GSK experienceDana E Vanderwall, Nancy Yuen, Mohammad Al-Ansari, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2009
Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitorsMark A Seefeld, Meagan B Rouse, Kenneth C McNulty, et al.
SLAS Discovery : Advancing Life Sciences R & D|April 28, 2018
Nuisance Compounds, PAINS Filters, and Dark Chemical Matter in the GSK HTS CollectionSubhas J Chakravorty, James Chan, Marie Nicole Greenwood, et al.
Stem Cells (Dayton, Ohio)|November 29, 2008
Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonistConnie L Erickson-Miller, Evelyne Delorme, Shin-Shay Tian, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
[3a,4]-Dihydropyrazolo[1,5a]pyrimidines: Novel, Potent, and Selective Phosphatidylinositol-3-kinase β InhibitorsHongyi Yu, Michael L Moore, Karl Erhard, et al.
Pageof 3